Immunological Surveillance of Cancer
Tumor immunology can be divided into two broad aspects. One of these deals with the immunology of established neoplasms and has as one of its important goals the development of clinically effective immunotherapy. Almost the entire armamentarium of immunology has been applied to this problem. Signs of progress are evident, but much still needs to be learned.
KeywordsRenal Transplant Recipient Ataxia Telangiectasia Cheek Pouch Tumor Immunology Immunological Defense
Unable to display preview. Download preview PDF.
- 2.Klein, G., 1973. Tumor immunology. Transpl. Proc. 5: 31.Google Scholar
- 3.Schwartz, R.S., 1975. Another look at immunologic surveillance. New Engl. J. Med. 293: 181.Google Scholar
- 5.Magee, B., 1973. “Karl Popper”, Viking Press.Google Scholar
- 8.Wortis, H.H., Nehlsen, S., and Owen, J. J., 1971. Abnormal development of the thymus in “nude” mice. J. Exp. Med. 134: 681, 1971.Google Scholar
- 9.Rygaard, J., 1973. “Thymus and Self”, John Wiley and Sons, New York.Google Scholar
- 10.Outzen, H.C., Custer, R.P., Eaton, G.J., et. al., 1975. Spontaneous and induced tumor incidence in germfree “nude” mice. J. Reticuloendothelial Soc. 17: 1.Google Scholar
- 11.Melief, C.J.M., and Schwartz, R.S., 1975. Immunocompetence and malignancy in “Cancer, a Comprehensive Treatise”, Vol. 1 ( F.F. Becker, Editor). Plenum Press, New York.Google Scholar
- 13.Friedman, J.M., and Fialkow, P.J., 1976. Cell marker studies of human tumorigenesis. Transplant. Rev. 28: 2.Google Scholar
- 16.Moller, G., and Moller, E., 1976. The concept of immunological surveillance against neoplasia. Transplant. Rev. 28: 1.Google Scholar
- 21.Byrnes, J.J., Downey, K.M., Black, V.L., and So, A.G., 1976. Azathioprine as a mutagen and carcinogen. J. Clin. Invest. 57: Abstract 461A.Google Scholar
- 23.Furth, J., 1975. Hormones as etiological agents in neoplasia in “Cancer: A Comprehensive Treatise” Vol. 1 ( F.F. Becker, Editor). Plenum Press, New York.Google Scholar